rhabdomylosis - Nursing Case Study
Pathophysiology
• Primary mechanism: Muscle cell damage leads to the release of intracellular contents, including myoglobin, into the bloodstream. This release is often triggered by intense physical exertion, trauma, or ischemia.
• Secondary mechanism: Myoglobin, a muscle protein, can obstruct renal tubules, causing acute kidney injury. Its breakdown products can also generate free radicals, exacerbating renal damage.
• Key complication: The accumulation of myoglobin in the kidneys can result in life-threatening electrolyte imbalances, such as hyperkalemia, which can lead to cardiac arrhythmias if not promptly managed.
Patient Profile
Demographics:
35-year-old male, construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes
• Current medications: Lisinopril, Metformin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Muscle weakness and dark urine
• Key symptoms: Muscle pain, fatigue, nausea, decreased urine output
• Vital signs: Temperature 100.4°F, Heart Rate 110 bpm, Blood Pressure 150/95 mmHg, Respiratory Rate 22 breaths per minute, Oxygen Saturation 94% on room air
Section 1
As the nursing team continues to monitor the patient's condition, they notice a change in his status. The patient's heart rate has increased to 125 bpm, and his blood pressure has risen to 160/100 mmHg. He appears more lethargic and exhibits increased muscle pain, particularly in his lower extremities. The patient's urine output has decreased further, with only 100 mL of dark, concentrated urine produced over the past four hours. These findings suggest a worsening of his renal function, likely due to the continued accumulation of myoglobin in the kidneys.
A set of laboratory tests is ordered to assess the patient's renal function and electrolyte balance. The lab results reveal elevated serum creatinine at 3.0 mg/dL, indicating acute kidney injury, and a dangerously high potassium level of 6.5 mEq/L, confirming hyperkalemia. Additionally, the patient's creatine kinase levels are markedly elevated at 15,000 U/L, reflecting significant muscle damage. These laboratory values, combined with the clinical findings, suggest that the patient is at increased risk for cardiac arrhythmias due to the hyperkalemia.
In response to these findings, the healthcare team initiates interventions to address the hyperkalemia and support renal function. The patient is started on intravenous fluids to promote renal perfusion and myoglobin clearance. Calcium gluconate is administered to stabilize cardiac membranes, and insulin with glucose is given to facilitate the intracellular shift of potassium. In addition, the nephrology team is consulted to evaluate the need for further interventions, such as dialysis. These actions aim to mitigate the risk of life-threatening complications while addressing the underlying cause of the patient's symptoms.
Section 2
Despite the initial interventions, the patient's condition continues to evolve, necessitating close monitoring and reassessment. Over the next few hours, the nursing team observes a change in the patient's status. His heart rate remains elevated at 120 bpm, and his blood pressure fluctuates, now reading 150/95 mmHg. The patient reports persistent muscle weakness and pain, with new-onset tingling sensations in his hands and feet. Additionally, his urine output remains critically low, with only 50 mL of dark urine in the subsequent four-hour period, indicating that renal perfusion and function are not improving as anticipated.
A repeat set of laboratory tests provides further insight into the patient's deteriorating condition. Serum creatinine has increased to 3.5 mg/dL, suggesting worsening acute kidney injury. Potassium remains elevated at 6.2 mEq/L despite initial interventions, indicating ongoing risk for cardiac complications. The patient’s calcium level is also noted to be low, at 7.8 mg/dL, which could contribute to neuromuscular irritability and exacerbate cardiac instability. These lab values reflect a continued imbalance that requires immediate attention to prevent further complications.
In response to these alarming developments, the healthcare team intensifies their efforts. The nephrology team recommends initiating hemodialysis to address the refractory hyperkalemia and support renal function. Additionally, the patient is placed on a cardiac monitor to detect any arrhythmias early. The nursing team collaborates with the multidisciplinary team to adjust the treatment plan, focusing on stabilizing the patient's electrolyte levels and enhancing renal recovery. This shift in management highlights the complexity of the patient's condition and sets the stage for further interventions aimed at preventing progression to a more critical state.
Section 3
As the nursing team closely monitors the patient following the initiation of hemodialysis, they observe a gradual stabilization in some of his vital signs. His heart rate begins to decrease, registering at 110 bpm, and his blood pressure shows a slight improvement, now reading 140/88 mmHg. However, despite these positive changes, the patient continues to report muscle weakness and a persistent tingling sensation in his extremities. The team conducts a thorough neurological assessment, noting diminished deep tendon reflexes and a positive Chvostek's sign, suggestive of hypocalcemia's neuromuscular effects.
The latest laboratory results post-dialysis reveal a modest improvement in the patient's electrolyte profile. Potassium levels have decreased to 5.5 mEq/L, indicating a partial response to the intervention. However, his calcium level remains critically low at 7.6 mg/dL, necessitating further management to prevent tetany or potential cardiac complications. Serum creatinine, while still elevated, shows a slight decrease to 3.3 mg/dL, suggesting early signs of renal recovery. Despite these improvements, urine output remains minimal, with only 100 mL noted over the next six-hour period, keeping the risk of acute kidney injury progression a significant concern.
The healthcare team decides to implement a calcium gluconate infusion to address the persistent hypocalcemia and closely monitors the patient's cardiac rhythm for any signs of arrhythmias. The patient is also provided with supportive therapy, including analgesia for muscle pain and ongoing fluid management to optimize renal perfusion. This approach aims to stabilize the patient's condition further while addressing the complex interplay of electrolyte imbalances and renal function, setting the stage for the next phase of his care, focused on enhancing recovery and preventing any new complications.
Section 4
As the patient continues under vigilant observation, the healthcare team notes a significant change in his status. Over the next 24 hours, the patient begins to experience increasing shortness of breath, accompanied by a rising respiratory rate, now at 28 breaths per minute. His oxygen saturation has decreased to 92% on room air, prompting the initiation of supplemental oxygen via nasal cannula. Additionally, the patient reports a new onset of mild chest discomfort and an escalating sense of fatigue, raising concerns about potential cardiac involvement or fluid overload.
The latest laboratory results reveal a further decline in calcium levels, now at 7.2 mg/dL, despite the ongoing calcium gluconate infusion. Magnesium levels have also dropped to 1.4 mg/dL, which may be contributing to the neuromuscular symptoms and altered cardiovascular status. The patient's electrolytes continue to reflect the delicate balance of his condition, with sodium levels slightly reduced at 132 mEq/L. The fluid management strategy is reevaluated in light of the minimal urine output and potential for fluid retention, which could exacerbate respiratory symptoms and cardiac strain.
In response to these developments, the healthcare team adjusts the patient's treatment plan. They increase the rate of calcium gluconate infusion and introduce magnesium sulfate to correct the hypomagnesemia. Diuretics are cautiously considered to manage fluid overload while monitoring renal function closely to prevent further compromise. An echocardiogram is ordered to assess cardiac function, given the chest discomfort and respiratory changes. These interventions aim to stabilize the patient's condition, addressing both the electrolyte imbalances and potential cardiac complications, while preparing for the next steps in his recovery journey.
Section 5
As the healthcare team closely monitors the patient's response to the adjusted treatment plan, they observe a change in his status that warrants immediate attention. Despite the increased calcium gluconate infusion and introduction of magnesium sulfate, the patient's respiratory distress worsens. His respiratory rate climbs to 32 breaths per minute, and oxygen saturation drops further to 88% on 3 liters of supplemental oxygen. The patient's shortness of breath is now accompanied by audible wheezing, and auscultation reveals bilateral crackles at the lung bases, suggesting fluid accumulation. The patient also reports increased chest discomfort, characterized by a pressure-like sensation that radiates to his left arm, raising the suspicion of myocardial ischemia.
New diagnostic results from the echocardiogram reveal a reduced ejection fraction of 40%, indicating compromised cardiac function, potentially due to stress from the underlying rhabdomyolysis and electrolyte imbalances. The electrocardiogram (ECG) shows T-wave inversions in the anterior leads, further suggesting myocardial strain. Additionally, repeat laboratory tests show a continued rise in creatine kinase levels, now at 12,000 U/L, and a slight increase in troponin levels, confirming cardiac involvement. The patient's minimal urine output, coupled with deranged kidney function tests, indicates worsening acute kidney injury, complicating fluid management and necessitating a delicate balance in diuretic use.
In response to these developments, the healthcare team initiates a low-dose diuretic regimen to address fluid overload while maintaining close monitoring of renal function. They also consider starting a low-dose beta-blocker to manage cardiac workload and provide symptomatic relief for the chest discomfort. The patient's electrolyte replacement is carefully titrated, with close observation for signs of further deterioration. These strategic interventions aim to stabilize the patient while preparing for potential escalation of care, such as transfer to a higher-level unit, should his condition continue to decline. The team remains vigilant, recognizing that the evolving complexities of the case require dynamic and informed decision-making to guide the patient's recovery.